Who is sponsoring NCT05748392?

NCT05748392 is sponsored by Solventum US LLC.

What drugs are being tested in NCT05748392?

Interventions in NCT05748392: Wound and per-wound assessments While using Device.

What condition does NCT05748392 study?

NCT05748392 studies WOUNDS INJURIES.

Is NCT05748392 still recruiting?

NCT05748392 is currently withdrawn. Last updated 1 October 2024.

Last reviewed 2024-10-01 · How we verify

NCT05748392

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3M Veraflo™ Cleanse Choice Complete™ (VFCCC) Clinical Study

Withdrawn NA Last updated 1 October 2024

What this trial tests

NA trial testing Wound and per-wound assessments While using Device in WOUNDS INJURIES. Withdrawn.

Timeline

1 June 2023

Primary endpoint
1 June 2023

1 June 2023

Quick facts

Lead sponsor	Solventum US LLC
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Start date	1 June 2023
Primary completion	1 June 2023
Estimated completion	1 June 2023
Sites	1 location across United States

Drugs / interventions tested

Wound and per-wound assessments While using Device

Conditions studied

WOUNDS INJURIES — all drugs for WOUNDS INJURIES →

Sponsor

Solventum US LLC — full company profile →

Who can join

22 and older, any sex, with WOUNDS INJURIES. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this external clinical study is to demonstrate the safety and performance of the Veraflo™ Cleanse Choice Complete™ Dressing Kit which will be used in conjunction with the V.A.C.® Ulta™ Therapy Unit, utilizing V.A.C. Veraflo™ Therapy instillation functions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Solventum US LLC trials

Trials by the same sponsor.

NCT05768373 — A Comparison Study of Hypersensitivity Treatment · NA · completed
NCT05361746 — Scotchbond Universal Plus Compared to Scotchbond Universal With Filtek Universal Restorative to Restore Class V NCCLs · NA · active not recruiting
NCT05248204 — Scotchbond Universal Plus Compared to Scotchbond Universal for Posterior Class I & II Restorations With Filtek Universal · NA · completed
NCT04906512 — Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy · NA · terminated
NCT04869696 — Medical Adhesive Repeat Application Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05748392 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Solventum US LLC
Last refreshed: 1 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05748392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing